Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    July 2021
  1. KORETZ RL
    In patients having transjugular intrahepatic portosystemic shunt, rifaximin prevented overt hepatic encephalopathy.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available


  2. TAPPER EB, Bosch J
    Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed    


    February 2021
  3. BUREAU C, Thabut D, Jezequel C, Archambeaud I, et al
    The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-0202.
    PubMed     Abstract available



  4. Summary for Patients: Laparoscopic Versus Open Surgery for Colorectal Liver Metastases.
    Ann Intern Med. 2021;174:I14.
    PubMed    


  5. AGHAYAN DL, Kazaryan AM, Dagenborg VJ, Rosok BI, et al
    Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases : A Randomized Trial.
    Ann Intern Med. 2021;174:175-182.
    PubMed     Abstract available


    September 2020
  6. VUKOTIC R, Raimondi F, Brodosi L, Vitale G, et al
    The Effect of Liraglutide on beta-Blockade for Preventing Variceal Bleeding: A Case Series.
    Ann Intern Med. 2020;173:404-405.
    PubMed    


    June 2020
  7. EIGENTLER T, Lomberg D, Machann J, Stefan N, et al
    Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade.
    Ann Intern Med. 2020;172:836-837.
    PubMed    


    December 2019
  8. LIBMAN H, Jiang ZG, Tapper EB, Reynolds EE, et al
    How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?
    Ann Intern Med. 2019;171:862.
    PubMed    


  9. PEARLMAN BL
    How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?
    Ann Intern Med. 2019;171:861-862.
    PubMed    


    August 2019
  10. SIMON TG, Duberg AS, Aleman S, Hagstrom H, et al
    Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Ann Intern Med. 2019 Aug 20. pii: 2748619. doi: 10.7326/M18-2753.
    PubMed     Abstract available


  11. KORULA J
    In compensated cirrhosis with portal hypertension, beta-blockers reduced a composite of decompensation or death.
    Ann Intern Med. 2019;171:JC21.
    PubMed    


  12. LIBMAN H, Jiang ZG, Tapper EB, Reynolds EE, et al
    How Would You Manage This Patient With Nonalcoholic Fatty Liver Disease?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2019;171:199-207.
    PubMed     Abstract available


    April 2019
  13. REYNOLDS EE, Buss MK, Schlechter BL, Tess A, et al
    Would You Refer This Patient With Cancer to a Palliative Care Specialist?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2019;170:488-496.
    PubMed     Abstract available


    February 2019
  14. MUSHER B, Rahal A
    Single-Agent Immunotherapy for Two Types of Cancer in One Patient.
    Ann Intern Med. 2019;170:210-211.
    PubMed    


  15. AL-SAMKARI H, Patel AA, Schiano TD, Kuter DJ, et al
    Recurrence of Acute Intermittent Porphyria After Liver Transplantation.
    Ann Intern Med. 2019 Feb 5. pii: 2724043. doi: 10.7326/L18-0623.
    PubMed    


    June 2018
  16. HAGHIGHAT L, Brandt EJ, Proctor DD, Garcia-Tsao G, et al
    Evolution of Intrahepatic Shunts in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Ann Intern Med. 2018 Jun 5. pii: 2683644. doi: 10.7326/L18-0036.
    PubMed    


    May 2018
  17. FEINGOLD-LINK M
    Cirrhosis.
    Ann Intern Med. 2018;168:630.
    PubMed    


    August 2017
  18. ZENNER D, Beer N, Harris RJ, Lipman MC, et al
    Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
    Ann Intern Med. 2017 Aug 1. doi: 10.7326/M17-0609.
    PubMed     Abstract available


    March 2017
  19. KAWANA Y, Imai J, Sawada S, Yamada T, et al
    Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report.
    Ann Intern Med. 2017;166:450-451.
    PubMed    


    January 2017
  20. CROWLEY MJ, Diamantidis CJ, McDuffie JR, Cameron CB, et al
    Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
    Ann Intern Med. 2017 Jan 3. doi: 10.7326/M16-1901.
    PubMed     Abstract available


    June 2016
  21. REUBEN A, Tillman H, Fontana RJ, Davern T, et al
    Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.
    Ann Intern Med. 2016;164:724-32.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: